Filing Details
- Accession Number:
- 0001209191-10-052780
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-03 10:24:11
- Reporting Period:
- 2010-10-22
- Filing Date:
- 2010-11-03
- Accepted Time:
- 2010-11-03 10:24:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1003642 | Impax Laboratories Inc | IPXL | Pharmaceutical Preparations (2834) | 650403311 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1336015 | Christopher Mengler | C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-10-22 | 2,000 | $21.26 | 29,666 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-10-25 | 40,956 | $21.24 | 7,460 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price reflecting the following individual transactions: 100 shares at $21.2716; 700 shares at $21.27; and 1,200 shares at $21.26.
- This total reflects the effect of other transactions that have occurred since the date of the reporting person's last Form 4.
- The price reported in Column 4 is a weighted average price reflecting the following individual transactions: 5,000 shares at $21.4424; 2,000 shares at $21.4265; 5,000 shares at $21.3731; 5,000 shares at $21.3479; 2,084 shares at $21.28; 16,666 shares at $21.1487; and 5,206 shares at $21.0266.